[go: up one dir, main page]

FI942392L - Peptidejä ja vasta-aineita nivelreuman hoitoon - Google Patents

Peptidejä ja vasta-aineita nivelreuman hoitoon Download PDF

Info

Publication number
FI942392L
FI942392L FI942392A FI942392A FI942392L FI 942392 L FI942392 L FI 942392L FI 942392 A FI942392 A FI 942392A FI 942392 A FI942392 A FI 942392A FI 942392 L FI942392 L FI 942392L
Authority
FI
Finland
Prior art keywords
peptides
antibodies
treatment
rheumatoid arthritis
rheumatoid
Prior art date
Application number
FI942392A
Other languages
English (en)
Swedish (sv)
Other versions
FI942392A0 (fi
FI942392A7 (fi
Inventor
Julian Kirby
Ian Victor Lewin
Sarita Maman
Denis Raymond Stanworth
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Publication of FI942392A0 publication Critical patent/FI942392A0/fi
Publication of FI942392A7 publication Critical patent/FI942392A7/fi
Publication of FI942392L publication Critical patent/FI942392L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI942392A 1991-11-25 1992-11-25 Peptidejä ja vasta-aineita nivelreuman hoitoon FI942392L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919125024A GB9125024D0 (en) 1991-11-25 1991-11-25 Rheumatoid arthritus treatment
PCT/GB1992/002174 WO1993011153A1 (en) 1991-11-25 1992-11-25 Peptides and antibodies for treatment of rheumatoid arthritis

Publications (3)

Publication Number Publication Date
FI942392A0 FI942392A0 (fi) 1994-05-24
FI942392A7 FI942392A7 (fi) 1994-05-24
FI942392L true FI942392L (fi) 1994-05-24

Family

ID=10705197

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942392A FI942392L (fi) 1991-11-25 1992-11-25 Peptidejä ja vasta-aineita nivelreuman hoitoon

Country Status (10)

Country Link
EP (1) EP0614464B1 (fi)
JP (1) JPH07507045A (fi)
AT (1) ATE163939T1 (fi)
AU (2) AU2951392A (fi)
CA (1) CA2123694A1 (fi)
DE (1) DE69224750D1 (fi)
ES (1) ES2112921T3 (fi)
FI (1) FI942392L (fi)
GB (2) GB9125024D0 (fi)
WO (1) WO1993011153A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416865D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of inflammatory diseases of the gastro-intestinal tract
GB9416864D0 (en) * 1994-08-19 1994-10-12 Peptide Therapeutrics Limited Treatment of IgA nephropathy
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
CN1174998C (zh) 1996-03-01 2004-11-10 诺瓦提斯公司 用于预防和治疗过敏的肽免疫原
CA2412513A1 (en) * 2000-06-22 2001-12-27 San Diego State University Foundation Modulators of recombination and methods for producing and using the same
WO2009158432A2 (en) 2008-06-27 2009-12-30 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
US11918624B2 (en) 2020-06-10 2024-03-05 Kelsius Laboratories LLC Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
US4701416A (en) * 1983-12-09 1987-10-20 Cetus Corporation Feline leukemia virus vaccine plasmids for fusion protein of the gp70 envelope protein of FELV
US4692511A (en) * 1984-07-03 1987-09-08 Immunetech Pharmaceuticals Peptide antagonists for the C5a anaphylatoxin
CA1327096C (en) * 1985-12-26 1994-02-15 Marta I. Sabara Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
GB8616174D0 (en) * 1986-07-02 1986-08-06 Antibody Technology Ltd Monoclonal antibodies
DK268889A (da) * 1988-06-07 1989-12-08 Smithkline Beckman Corp Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
GB2220939B (en) * 1988-06-10 1992-02-26 Medical Res Council Peptide fragments of hiv and their use in vaccines and diagnosis
FR2646425B1 (fr) * 1989-04-26 1991-08-30 Neosystem Sa Peptides synthetiques du conjugue de l'ubiquitine et de l'histone h2a
EP0471752A4 (en) * 1989-05-08 1992-09-02 Idexx Corp. Polypeptides of feline t-cell lymphotropic lentivirus
GB2246780B (en) * 1990-05-25 1994-04-27 Nat Res Dev Immunodiagnostic assay for rheumatoid arthritis
CA2060699A1 (en) * 1991-02-11 1992-08-12 Isia Bursuker Gm-csf inhibiting oligopeptides

Also Published As

Publication number Publication date
WO1993011153A1 (en) 1993-06-10
JPH07507045A (ja) 1995-08-03
FI942392A0 (fi) 1994-05-24
FI942392A7 (fi) 1994-05-24
AU2951392A (en) 1993-06-28
CA2123694A1 (en) 1993-06-10
AU7196596A (en) 1997-02-06
EP0614464B1 (en) 1998-03-11
DE69224750D1 (de) 1998-04-16
GB2261665B (en) 1995-11-08
ATE163939T1 (de) 1998-03-15
GB2261665A (en) 1993-05-26
ES2112921T3 (es) 1998-04-16
EP0614464A1 (en) 1994-09-14
GB9224684D0 (en) 1993-01-13
GB9125024D0 (en) 1992-01-22

Similar Documents

Publication Publication Date Title
FI962377A7 (fi) Humanisoituja vasta-aineita ja niiden käyttö
DE69434520D1 (de) Biotinylierung von proteinen
NO940219D0 (no) Rekombinante antistoffer for human terapi
DE69329848D1 (de) Poymerisationsverfahren und daraus hergestellte tonerzusammensetzungen
DE69229254D1 (de) Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper
EP0692536A3 (en) Protein that induces interferon gamma production and monoclonal antibodies against it
NO921863L (no) Antistoffer og anvendelse derav
FI960978L (fi) Anti-GP39-vasta-aineet ja niiden käyttö
FI944885A7 (fi) Tölkin perusosa
NO960956D0 (no) Rekombinante IL4-antistoffer anvendelige ved behandling av IL4-betingede forstyrrelser
FI952574L (fi) Glykosyylitransferaasiaktiiviset proteiinit
IT1232273B (it) Anticorpo umano monoclonale ed ibridoma che produce il medesimo
KR970703146A (ko) 류마티스성 관절염의 치료방법 및 시약(method and reagents for the treatment of rheumatoid arthritis)
FI942392L (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
IT1231727B (it) Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
NO961747D0 (no) Behandling av reumatoid artritt
DE69423708D1 (de) Detektion von globaler Translation zwischen Bildern
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
FI945485L (fi) Monoklonaaliset vasta-aineet ja niiden käyttö
FI942184L (fi) Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita
FI974171A0 (fi) Metotreksaatin ja tenidapin yhdistelmä nivelreuman hoitoon
DE59107525D1 (de) Peptidamidase und deren Verwendung
DE69331549D1 (de) Nachweiss von anti-hpa antikörpern
DK604589A (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DK604689A (da) Peptider, og analysesaet med indhold af saadanne forbindelser